Phosphorylation
of glutamate receptors (GluRs) is emerging as an important regulatory mechanism.
In this study 32P labeling of non-NMDA GluRs was investigated in cultured hippocampal neurons stimulated 2-15 min with agonists that selectively stimulate either Ca2+/calmodulin-dependent protein kinase II (CaM-kinase II), Ca*+/phospholipid-dependent protein kinase C (PKC), or CAMP-dependent protein kinase A (PKA). Treatment of hippocampal neurons with glutamate/ glycine (Glu/Gly), ionomycin, or 12-O-tetradecanoylphorbol 13-acetate (TPA) increased 32P labeling of immunoprecipitated cY-amino-3-hydroxy-5-methyl-4-isoxazoleproprionate (AMPA)-type GluRs by 145%, 180%, and 227%, respectively, of control values. This increased phosphorylation of GluRs was predominantly 32P-Ser with little 32P-Thr and no detectable32P-Tyr.
GlulGly and ionomycin, but not TPA, also increased 32P labeling of CaM-kinase II by 175% and 195%, respectively, of control values. Of these three agonists, only TPA stimulated phosphorylation of MARCKS (225% of control), a specific substrate of PKC. Forskolin treatment gave a three-to fourfold increase in the active catalytic subunit of PKA but did not result in the 32P labeling of AMPA-type GluRs, CaM-kinase II, or MARCKS. Phosphorylation of GluRs in response to Glu/Gly was blocked by a specific NMDA receptor/ion channel antagonist (DL-2-amino-5phosphon-ovaleric acid) or by a cell-permeable inhibitor of CaM-kinase II (1 -[N,O-bis( 1,5-isoquinolinesulfonyl)-Kmethyl-L-tyrosyl]-4-phenylpiperazine, . These results are consistent with the hypothesis that Ca *+ influx through the NMDA-type ion channel can activate CaM-kinase II, which in turn can phosphorylate and regulate AMPA-type GluR ion channels (McGlade-McCulloh et al., 1993 Glutamate is the major neurotransmitter at excitatory synapses, where it stimulates multiple types of glutamate receptors (GluRs) including non-NMDA receptor/ion channels, NMDA-type ion channels, and metabotropic receptors that are primarily coupled to G-proteins (Gasic and Hollmann, 1992) . Non-NMDA receptor/ion channels, which are primarily permeable to Na+ and K+, mediate normal rapid synaptic transmission, whereas NMDA-type ion channels, which have additional permeability to Ca2+, are normally inactive due to a voltage-dependent Mgz+ blockage. Some usage-dependent forms of learning and memory, such as long-term potentiation (LTP) in region CA1 of hippocampus, require activation of NMDA receptors to allow postsynaptic influx of Ca2+ (Madison et al., I99 1) . Considerable evidence implicates roles for protein kinases in LTP (Meffert et al., 199 l) , so it was reasonable to test whether the required Ca2+ influx through the NMDA ion channel involved activation of postsynaptic Ca*+-dependent protein kinases. Indeed, postsynaptic infusion of peptide inhibitors of protein kinase C (PKC) or Ca2+/calmodulin-dependent protein kinase II (CaM-kinase II) blocks induction of LTP in hippocampus (Malinow et al., 1989) . Furthermore, mice that lack the cy isoform of CaM-kinase II, the major protein in the postsynaptic density (PSD) of these glutaminergic synapses (Kennedy et al., 1983) are deficient in hippocampal LTP (Silva et al., 1992a) and another form of hippocampal learning, the Morris water test (Silva et al., 1992b) . Thus, considerable evidence implicates involvement of CaMkinase II in learning and memory (Soderling, 1993) . Over the past several years we have attempted to provide a molecular understanding for possible involvement of CaM-kinase II in models of synaptic plasticity such as LTP. We have focused on two questions: (1) does Ca'+ influx through the NMDA receptor, as required for initiation of LTP, result in activation of CaM-kinase II, and (2) does activated CaM-kinase II phosphorylate and regulate non-NMDA GluRs? Regulation of GluRs by CaM-kinase II is of particular interest since the Ca*+/CaM-activated kinase rapidly autophosphorylates, thereby generating a constitutively active, Ca2+-independent kinase (Colbran and Soderling, 1990; Hanson and Schulman, 1992) that may act as a molecular sensor of synaptic frequency (Lisman, 1989) . We have demonstrated that treatment of cultured cerebellar granule cells (Fukunaga et al., 1989 (Fukunaga et al., , 1990 or hippocampal neurons (Fukunaga et al., 1992) with glutamate/glytine (Glu/Gly) activates CaM-kinase II through autophosphorylation and generation of the Ca2+-independent form. This activation of CaM-kinase II by Glu/Gly was blocked by specific NMDA antagonists. We have also investigated phosphorylation and regulation of GluRs by CaM-kinase II and have focused on the non-NMDA, cu-amino-3-hydroxy-5-methyl-4-isoxazoleproprionate (AMPA)-type ion channels (GluR I-GluR4) for the following reason. Data over the past several years indicate both presynaptic and postsynaptic components for the increased synaptic efficacy during expression of LTP. The presynaptic aspect appears to involve increased release of glutamate (Bekkers and Stevens, 1990) , whereas the postsynaptic component is due to increased responsiveness of GluRs (Davies et al., 1989) . This enhanced postsynaptic responsiveness presumably involves non-NMDA GluRs as non-NMDA antagonists, but not NMDA antagonists, block the expression of LTP (Madison et al., 199 1 (Greengard et al., 199 1; Wang et al., 199 1, 1993; Keller et al., 1992; Raymond et al., 1993) , so effects of PKA and PKC activation were also studied.
Materials and Methods
Materials. The following chemicals and reagents were purchased from the indicated sources. Fetal calf serum, horse serum, trypsin, trypsin inhibitor, minimum essential medium, and microcystin-LR, GIBCO/ Bethesda Research Labs; poly-L-lysine, transferrin, putrescine, sodium selenite, triiodothyronine, progesterone, corticosterone, insulin, cytosine-P-arabinofuranoside, L-glutamate, glycine, CAMP, kemptide, phosphoserine, phosphothreonine, and phosphotyrosine, Sigma Co.; 32P-orthophosphate, ICN; y-)'P-ATP, DuPont-New England Nuclear; ionomycin, O-tetradecanoylphorbol 13-acetate (TPA), and forskolin, Calbiochem; PKI-tide (PKA peptide inhibitor) and PKC,,_,, peptide, Peninsula Laboratories; I-[N,O-bis(l,5-isoquinolinesulfonyl)-N-methyl-L-tyrosyll-4-phenylpiperazine (KN-62), Seikagaku; DL-2-amino-5-phosphonovaleric acid (APS), Cambridge Research Biochemicals; protein-A-Sepharose CL-4B and GammaBind G-Sepharose, Pharmacia LKB Biotechnology; anti-MARCK antiserum was a gift from Dr. Blackshear at Duke University. Other supplies were commercially available and were used at the condition specified by the manufacturer.
Cell culture. Hippocampal primary cultures were prepared from newborn pups (Sprague-Dawley, Simmerson, CA), according to the method of Lester et al. (1989) . The hippocampal cells were seeded at a density of 2 x lo6 cells per 35 mm tissue culture dishes (Falcon) that were precoated with poly+lysine. After 24 hr, cells were treated with 10 PM cytosine-&arabinofuranoside to stop non-neuronal cell replication. The culture medium was replaced with fresh growth medium without fetal calf serum at 4 and 7 d of culture. The cells were maintained in a 37°C humidified incubator with 95% air and 5% CO,.
In situ jzP labeling. Ten-day-old cultures were maintained in phosphate-free minimum essential medium for 12 hr before j'P0, (1 mCi/ ml) labeling for 1 hr. The cells were then preincubated for 30 min in Kreb-Ringer HEPES buffer (KRH) without calcium as described (Fukunaga et al., 1992) . In some experiments KN-62 or AP5 was also present during this preincubation. For those experiments containing KN-62, the experimental and control incubations contained 0.3% dimethyl sulfoxide as solvent. Cells were stimulated with the indicated agonist in KRH containing 2.7 mM CaCI, but without magnesium (Fukinaga et al., 1992) . After stimulation, KRH was aspirated,RIPA buffer 150 mM Tris-HCl. 150 mM NaCI. 10 mM EDTA. 2 mM EGTA. 15 mM NaPPi, 50 mM NgF, 100 mM &lycerophosphaie, 0.5 /LM miciocystin, 0.1% SDS, 1% NP-40, plus 20 pg/ml soybean trypsin inhibitor, 5 kg/ ml leupeptin, 5 pg/ml aprotinin, and 1 mM phenylmethylsulfonyl fluoride (PMSF), pH 7.51 was added, and the cells were frozen in liquid nitrogen.
Immunoprecipitation and quantification of "P-labeled proteins. Cells were thawed and scraped into a 1.5 ml microcentrifuge tube. The lysates were centrifuged, and the supernatants were saved for immunoprecipitation experiments. Five microliters of the samples were TCA (trichloroacetic acid) precipitated, dissolved in 0.1 N NaOH, and reprecipitated with TCA. Total radioactivity was equated for the samples before the immunoprecipitation.
Immunoprecipitations were performed in duplicate or triplicate for each condition. Supernatants were precleared with normal nonimmune serum followed by precipitation with protein-A-Sepharose CL-4B (PAS). The supernatant was then transferred to a new tube and incubated with specific antiserum for either CaM-kinase II, GluRl, or myristoylated alanine-rich C kinase substrate (MARCKS) for 16 hr at 4°C. Protein-A-Sepharose was added for 30 min. The PAS-antibody-antigen complexes were pelleted and washed four times with 50 mM Tris-HCI (pH 8.3), 0.6 M NaCI, 0.5% Triton X-100 plus 0.1 mM PMSF. GammaBind-G-Sepharose was used for the immunoprecipitation using anti-CaM-kinase II antiserum since the antiserum was obtained from goat. Immunoprecipitates were solubilized in SDS sample buffer followed by boiling for 2 min. Proteins were fractionated bv SDS-PAGE (Laemmli. 1970) . and DhOSDhODrOteins were visualizeb by autoradidgraphy. The i'P'incoGoration -was quantified by densitometric scanning (Bio-Rad).
Immunoblotting. After SDS-PAGE, the proteins were transferred onto polyvinylidene difluoride membrane (Immobilon, Millipore). The membrane was blocked with 5% nonfat milk in 25 mM Tris-HCl pH 7.5, 150 mM NaCI, 0.2% Tween-20 for 2 hr at room temperature. The blot was then rinsed in buffer (without milk) and incubated with GluR 1 antiserum for 1 hr. After another rinse, the blot was incubated with horseradish peroxidase-conjugated donkey anti-rabbit IgG for 30 min. The protein bands recognized by antibody were visualized by the chemiluminescence method (ECL, Amersham).
Phosphoamino acid analysis. The AMPA-type )'P-GluR transferred from SDS-PAGE to Immobilon membrane was cut out and washed with methanol followed by water for several hours. The blot was then subjected to acid hydrolysis in 20 ~1 of 6 N HCI at I 10°C for 1 hr. After centrifugation, the sample was dried using a Speed-Vat concentrator (Savant) and solubilized with 5 ~1 of aqueous buffer containing 1 mg/ ml each of phosphoserine, phosphothreonine, and phosphotyrosine. These samples were then spotted on a cellulose plate (EM Chemicals) and subjected to electrophoresis at 1.5 kV for 45 min using pH 3.5 buffer (glacial acetic acid, pyridine, water, 5:0.5:94.5, v/v/v). Standards were detected by ninhydrin staining, whereas the radiolabeled samples were visualized by autoradiography.
In vitro kinase assays. After agonist treatment, cells were aspirated and suspended at 5°C in 0.3 ml of 10 mM potassium phosphate (pH 6.8), 10 mM EDTA, 0.5 mM 1-methyl-3-isobutylxanthine (IBMX) plus 0.1 mM leupeptin, 5 fig/ml aprotinin, 75 FM pepstatin A, and 1 mM dithiothreitol to determine the activation ratio of PKA (Soderling et al., 1973) . After sonication the insoluble fraction was removed by centrifugation at 13,000 x g for 5 min. The PKA reaction mixture contained 10 mM potassium phosphate (pH 6.8), 10 mM magnesium acetate, 1 mM EGTA, 0.4 mM rJZP-ATP (1000-2000 cpm/pmol), 60 PM kemptide, with or without 1 FM CAMP in a volume of 25 ~1. For determining CaM-kinase II activation the cells were suspended in 0.3 ml of 50 mM HEPES (pH 7.5), 10 mM EDTA, 4 mM EGTA, 15 mM sodium pyrophosphate, 25 mM NaF, 100 mM P-glycerophosphate, 0.5 PM microcystin, 0.1% Triton X-100, plus 75 KM pepstatin A, 5 &ml leupeptin, and 5 Kg/ml aprotinin (Fukunaga et al., 1992) . Cells were sonicated and centrifuged as for PKA. The CaM-kinase II activities were measured using syntide-2 as the substrate (Hashimoto and Soderling, 1987) . The standard kinase assay contained 50 mM HEPES (pH 7.5), 10 mM magnesium acetate, 0.4 mM y-12P-ATP (1000-2000 cpm/pmol), 40 PM syntide-2, 2 PM PKC inhibitor peptide, and 5 FM PKI-tide in a volume of 25 ~1. To measure total CaM-kinase II activity, the reaction mixture contained 0.5 mM CaC12, 2 PM CaM. For Ca"-independent kinase activity, 1 mM EGTA was present during the assay. All kinase reactions were initiated by addition of cell extract. After incubating at 30°C for 3 min, a 15 ~1 aliquot was spotted on a P-cellulose paper, which was washed and counted by liquid scintillation counter (Roskoski, 1985) .
Other methods. The cDNAs for GluR 1 and GluR3, kindly provided by Drs. Hollmann and Heinemann, were inserted into a Friend spleen focus-forming virus 5' long terminal repeat expression plasmid (Fuhlbrigge et al., 1988) . Transformed human embryonic kidney (293) cells were transiently transfected with these plasmids and lysed 60 hr later.
Two-dimensional peptide mapping of the tryptic digest of "lP-GluR isolated from Glu/Gly-stimulated cells was performed as described previously (McGlade-McCulloh et al., 1993) using the Hunter Thin Layer Electronhoresis svstem (HTLE-7000. CBS Scientific Co.). Electronhoresis was performed for'50 min at 1 'kV, and chromatography was for 16 hr using n-butanol, pyridine, acetic acid, and water in volume ratios of 0.375:0.25:0.075:0.30.
Results and Discussion
The expression of AMPA-type GluRs and CaM-kinase II in cultures of hippocampal neurons was assessed by Western analysis and kinase assays, respectively. CaM-kinase II activity increased with time of culturing up to a maximum of 20,nmoV min/mg at 10 d. AMPA-type GluR immunoreactivity also increased with time of culture up to 8 d in culture (not shown). We therefore chose to maintain our cells for 10 d in culture prior to use. At this time about 30% of the cells were nonneuronal as determined by comparing immunohistochemical staining with anti-glial fibrillary acidic protein antibody to staining with GluRl antibody (not shown). It has been previously shown in these cultured cells that almost all the immunoreactive CaM-kinase II is localized to the neurons (Fukunaga et al., 1992) . Therefore, the 32P labeling of GluRs by CaM-kinase II is occurring almost exclusively in the neurons.
This study employs immunoprecipitation of AMPA-type 32P-GluRs using an antibody against a synthetic peptide corresponding to the extreme COOH terminus of GluR 1 (Ab7 of Wenthold et al., 1992) . A previous characterization of this GluRl Ab7 has shown by Western analysis of GluRl-GluR4 expressed in COS cells that the antibody is specific for GluR 1. However, Ab7 coimmunoprecipitates all four subunits from solubilized rat brain membranes , indicating that native AMPA-type GluRs are heteromeric complexes of GluRl-GluR4. Coprecipitation of all four GluR subunits depends on the specific immunoprecipitation conditions. In our previous study of GluR phosphorylation in isolated rat synaptosomes and PSDs (McGlade-McCulloh et al., 1993 ) these preparations were solubilized with 1% SDS, which was then diluted lo-fold with RIPA buffer prior to immunoprecipitation. Under those conditions, Ab7 immunoprecipitates were not immunoreactive (S. E. Tan, unpublished observation) using an antibody against GluR2/3 (Ab25 of Wenthold et al., 1992) . In the present study our immunoprecipitation conditions are slightly different than in the two previous studies, so it was necessary to establish which GluR subunits were immunoprecipitated by GluR 1 Ab7. Figure 1 shows that Ab7 immunoprecipitates from the hippocampal cell extract give strong immunoreactivity on Western analysis to GluRl Ab7 (Fig. IA, lane 1) and to GluR2/3 Ab25 (Fig. lB, lane 1) . Lanes 2 and 3 confirm the specificities of these two antibodies using extracts from kidney 293 cells expressing either GluRl (lane 2) or GluR3 (lane 3). Thus, our present were subjected to SDS-PAGE and Western blot analysis using antibody to GluR 1 (A) or antibody to GluR2/3 (B). The region of the autoradiograph containing the GluRs was scanned with a Nikon film scanner and converted into a digital image, which was transferred to a composite graphics program.
conditions give immunoprecipitation of the heteromeric GluR complex containing at least GluRl-3. We did not specifically test for coimmunoprecipitation of GluR4, but since GluR4 is part of the heteromeric complex immunoprecipitated by Ab7 , we probably are also coprecipitating GluRI-GluR4. However, it should be noted that hippocampus contains very little GluR4 compared to GluRl-GluR3 (Petralia and Wenthold, 1992) .
Our previous study has shown that CaM-kinase II is a strong catalyst for in vitro phosphorylation of GluRl (McGladeMcCulloh et al., 1993) and that treatment of hippocampal neurons with Glu/Gly activates CaM-kinase II by stimulation of NMDA receptors with resultant Ca'+ influx (Fukunaga et al., 1992) . We also demonstrated that activated CaM-kinase II can enhance AMPA-type GluR ion current in hippocampal neurons (McGlade-McCulloh et al., 1993) . The next logical step was to examine whether Glu/Gly treatment of hippocampal neurons increased phosphorylation of AMPA-type GluRs through activation of CaM-kinase II. For purposes of comparison, we also wanted to activate selectively CaM-kinase II, PKC, or PKA using other agonists and chose ionomycin, TPA, and forskolin, respectively, for this purpose. We had previously shown (Fukunaga et al., 1992 ) that 30 min preincubation of the hippocampal neurons in KRH buffer without Ca*+ reduced the Ca2+-independent activation state of CaM-kinase II from a basal value of 5-6% to l-2%. Upon addition of Ca2+ (2.7 mM) alone, the kinase immediately returned to its basal 5-6% Ca2+ independence. We therefore used this treatment paradigm in the present study. Glu/Gly were used as coactivators of the NMDA ion channel in the absence of extracellular Mg*+ to avoid voltage-dependent Mg2+ blockage (Gasic and Hollmann, 1992) . Initial time course studies (not shown) were performed to determine optimal times for 32P labeling of GluRs by the various agonists. Figure 2 illustrates data from a single experiment on the 32P labeling of several proteins in response to Glu/Gly or TPA treatment. In this experiment Glu/Gly (10 PM/ 1 PM for 5 min) increased phosphorylation of AMPA-type GluRs and of CaMkinase II with no effect on MARCKS, the myristoylated alaninerich C kinase substrate (McIllroy et al., 199 1) . TPA (1 MM for 15 min) increased phosphorylation of GluRs and MARCKS protein with no effect on phosphorylation of CaM-kinase II. Analysis of 3ZP labeling of proteins by this approach involves multiple steps that are subject to experimental variability, so in Figure 3 show a composite graph from a number of separate experiments that permits statistical analysis of the data. Glu/Gly increased phosphorylation of GluRs to 145 f 10% (p < 0.005) and of CaM-kinase II to 175 + 21% (p < 0.005) of control values. Ionomycin, a divalent cation ionophore, gave a similar response by increasing GluR and CaMkinase II phosphorylations to 180 + 25% (p < 0.001) and 195 + 22% (p < 0.00 l), respectively, ofcontrols. GluR and MARCKS protein phosphorylations were enhanced to 227 + 27% and 168 f 7% of controls, respectively, by TPA treatment. When ,*PGluRs from control, Glu/Gly, and TPA treatments were excised from the gels of two experiments and analyzed for 32P-amine acid contents, the average distribution between '*P-Ser and 32P-Thr, respectively, was as follows: control, 60%, 40%; Glu/Gly, 68%, 32%; and TPA, 73%, 27%. This indicates that 80-90% of the increased phosphorylation of GluRs in response to Glu/Gly or TPA was on Ser. This is consistent with the fact that the consensus CaM-kinase II (Ser 627, numberings based on GluR 1) and PKC (Ser 650, 658, and 676) phosphorylation sites on the intracellular loop of GluR I-GluR4 are predominantly serines (Keingnen et al., 1990; Egebjerg et al., 199 1) . We did not detect any 32P-Tyr in spite of the fact that NMDA receptor stimulation can activate tyrosine kinases (Bading and Greenberg, 199 1) and that GluRl expressed in kidney 293 cells was phosphorylated on Tyr by coexpressed v-src tyrosine kinase (Moss et al., 1993) . The above results suggest that AMPA-type GluR phosphorylation in response to stimulation by Glu/Gly or ionomycin is due to CaM-kinase II activation, whereas the TPA effect is mediated by PKC. Although more complicated scenarios can be postulated, the data would tend to exclude them. For example, ionomycin and Glu/Gly might be expected to activate PKC, and, in fact, we have demonstrated that the Glu/Gly treatment does give translocation of PKC from the cytosol to the membrane fraction (Fukunaga et al., 1992) . However, this translocation was very transient in that it was maximal at about 15 set and had returned to the basal value within 2 min. The fact that MARCKS protein was not phosphorylated in response to either Glu/Gly (5 min) or ionomycin (2 min) (Fig. 3 ) also indicates that PKC activation was certainly minimal. Scholz and Palfrey observed very transient phosphorylation of MARCKS that was elevated at 30 set but not at 2 min after glutamate treatment of hippocampal neurons (Scholz and Palfrey, 199 1) . Another possibility is that TPA activation of PKC with MARCKS phosphorylation could result in release of CaM, which would activate CaM-kinase II (MacNicol and Schulman, 1992) . MARCKS binds CaM in a Ca2+-independent manner, and phosphorylation of MARCKS by PKC promotes release of CaM (McIlroy et al., 1991) . This mechanism does not appear to underlie the TPA effect on GluR phosphorylation since TPA does not increase the 32P labeling of CaM-kinase II (Fig. 3 ). This conclusion is substantiated in Figure 4 , where the activation state of CaM-kinase II was measured. Since CaM-kinase II contains multiple autophosphorylation sites, only one of which regulates generation of Ca*+-independent activity (Colbran and Soderling, 1990; Hanson and Schulman, 1992) , measurement of Ca*+ -independent activity is probably a more sensitive index of CaM-kinase II activation. Figure 4 (left) shows that although Glu/Gly and ionomycin both increase Ca*+-independent CaMkinase II, TPA has little if any effect. Figure 4 (right) verifies that forskolin treatment of the hippocampal neurons strongly activated PKA even though it had no effect on phosphorylation of AMPA-type GluR.
Although the data of Figure 3 suggest that the Glu/Gly enhancement of AMPA-type GluR phosphorylation was mediated by activation of CaM-kinase II, we wanted to test this hypothesis further. For this purpose we used KN-62, a cell-permeable inhibitor of the CaM-kinase family. KN-62 inhibits CaM-kinase II competitively with Ca*+/CaM, so it has no inhibitory effect on PKC or PKA (Hidaka and Kobayoshi, 1992) . It also shows little or no inhibition in vitro (Hidaka and Kobayoshi, 1992) or in cultured smooth muscle cells (Tansey et al., 1992) toward myosin light chain kinase, another Ca*+/CaM-dependent protein kinase. Preincubation of hippocampal neurons with 10 PM KN-62 reduced basal phosphorylation of both GluR and CaMkinase II and blocked the stimulatory response to Glu/Gly (Fig.  5, top) but not the response to TPA (not shown). This is very strong evidence that the enhanced phosphorylation of AMPA- by CaM-kinase activation.
Since CaM-kinase II is by far the most prominent II (see Fig. 1 Kennedy, 1985) and is the major PSD protein (Kennedy (Fukunaga et al., 1992) . The transient PKC translocation is not et al., 1983) the Glu/Gly response is probably mediated by due to NMDA receptor activation, but it appears to require CaM-kinase II. Further evidence for this conclusion is the fact stimulation of the metabotropic GluR (Fukunaga et al., 1992 ) that the two-dimensional peptide map of GluR phosphorylated which is coupled to phospholipase C activation (Gasic and Hollin response to Glu/Gly (Fig. 6 ) is similar if not identical to the mann, 1992). Since the phosphorylation of AMPA-type GluR Figure 3 . Effects of agonists on 32P labeling in cultured hippocampal neurons. Autoradiographs from many experiments were quantitated relative to the appropriate control using a Bio-Rad scanning densitometer. Controls contained the appropriate solvents used for each agonist. Experimental treatments were as follows: Glu/Gly, 10 PM/~ ILM, for 5 min; ionomycin, 5 PM, for 2 min; forskolin, 10 GM, for 15 min; TPA, 1 PM, for 15 min. Data are given as mean t SE, and statistical analysis was performed using the Student's t test.
Control
Glu/Gly Ion0 TPA Forskolin Control Forskolin Figure   4 . Activation of CaM-kinase II and PKA. Cultured hippocampal neurons were treated identically to experiments in which 12P labeling was measured except the cells were not metabolically labeled. Cells were stimulated with Glu/Gly (10 PM/~ PM, 5 min), ionomycin (5 PM, 2 min), TPA (1 FM, 15 min), or forskolin (10 PM, 15 min). For the graph to the /eji the cells were homogenized in CaM-kinase II homogenization buffer (see Materials and Methods) and assayed for CaM-kinase II activity using syntide-2 as substrate in the presence of EGTA (Cal+-independent activity) or Ca*+/CaM (total activity). The ratios of these two activities times 100 gives the percentage of Ca *+-independent activity. For the graph to the right the cells were homogenized in 10 rnM potassium phosphate (pH 6.8), 10 mM EDTA, 0.5 mM IBMX and assayed for PKA activity using kemptide as substrate in the absence and presence of CAMP. The ratio of these two activities gives the fraction of PKA in the active catalytic subunit (Soderling et al., 1973) . See Materials and Methods for exact conditions of protein kinase assays. Data are given as mean + SE, n = 3. The SE for the TPA effect is too small (0.03) to show on the plot. . Peptide map of AMPA-type GluR phosphorylated in response to Glu/Gly. Hippocampal cells were labeled,and stimulated with Glu/Gly, and the immunoprecipitated '*P-GluR was run on SDS-PAGE as in Figure 2 . The radioactive GluR band was excised from the gel, digested with trypsin, and subjected to two-dimensional peptide mapping. The arrow marks the origin.
by Glu/Gly is completely blocked by the NMDA antagonist APS (Fig. 5, bottom) , this further supports the conclusion that CaM-kinase II is involved in this response.
The above experiments confirm and extend our previous study using in vitro preparations that showed CaM-kinase II and PKC, but not PKA, could phosphorylate GluR 1 (McGlade-McCulloh et al., 1993) . This is consistent with the presence of consensus phosphorylation sites for CaM-kinase II and PKC, but not PKA, on the major intracellular loop of GluRl-GluR4 (Keinanen et al., 1990; Egebjerg et al., 1991) . PKC appears to be a much stronger catalyst, compared to CaM-kinase II, of AMPA-type GluR phosphorylation in the cultured hippocampal neurons than it was of GluRl phosphorylation in vitro (McGladeMcCulloh et al., 1993) . Possible reasons could be that other GluR subunits (i.e., GluR2-GluR4) may contain better PKC phosphorylation sites than GluR 1, or PKC isoforms in hippocampal cells are better catalysts than the (Y isoform used in vitro. It should be noted that although PKA does not directly phosphorylate AMPA-type GluRs, it does enhance non-NMDA ion current in hippocampal neurons (Greengard et al., 1991; Wang et al., 199 l) , perhaps through phosphorylation of GluR6 (Ray-mond et al., 1993; Wang et al., 1993) . The mechanism whereby PKA enhances kainate current in oocytes expressing GluR 1 and GluR3 (Keller et al., 1992 ) is unclear. Although phosphorylation of a regulatory protein associated with GluRs is a possibility, evidence for a regulatory protein that coimmunoprecipitates with AMPA-type GluRs is lacking ). Another possibility would be inhibition of phosphatase 1 by PKAmediated phosphorylation of inhibitor 1 (Huang and Glinsmann, 1976 The data of Figures 3 and 5 demonstrate that NMDA receptor stimulation in hippocampal neurons results in activation of CaMkinase II, which in turn phosphorylates AMPA-type GluRs. Combined with our previous demonstration that infusion of activated CaM-kinase II into hippocampal neurons results in enhanced non-NMDA ion current (McGlade-McCulloh et al., 1993) and the colocalization of CaM-kinase II and GluRs in the PSDs of glutaminergic neurons, the following hypothesis can be formulated. Paradigms such as LTP that result in activation of NMDA ion channels could activate PSD CaM-kinase II with resultant phosphorylation of AMPA-type GluRs. Indeed, it has just been reported that induction of LTP does give stable activation of CaM-kinase II (Fukunaga et al., 1993) .
